Mechanisms of Aβ Clearance and Degradation by Glial Cells
Tóm tắt
Từ khóa
Tài liệu tham khảo
Abraham, 1989, α1-Antichymotrypsin is present together with the β-protein in monkey brain amyloid deposits., Neuroscience, 32, 715, 10.1016/0306-4522(89)90292-3
Abraham, 2001, Reactive astrocytes and α1-antichymotrypsin in Alzheimer’s disease., Neurobiol. Aging, 22, 931, 10.1016/S0197-4580(01)00302-5
Alarcon, 2005, Expression of scavenger receptors in glial cells. Comparing the adhesion of astrocytes and microglia from neonatal rats to surface-bound beta-amyloid., J. Biol. Chem., 280, 30406, 10.1074/jbc.M414686200
Azevedo, 2009, Equal numbers of neuronal and nonneuronal cells make the human brain an isometrically scaled-up primate brain., J. Comp. Neurol., 513, 532, 10.1002/cne.21974
Bacskai, 2002, Non-Fc-mediated mechanisms are involved in clearance of amyloid-beta in vivo by immunotherapy., J. Neurosci., 22, 7873, 10.1523/JNEUROSCI.22-18-07873.2002
Bamberger, 2003, A cell surface receptor complex for fibrillar beta-amyloid mediates microglial activation., J. Neurosci., 23, 2665, 10.1523/JNEUROSCI.23-07-02665.2003
Bard, 2000, Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease., Nat. Med., 6, 916, 10.1038/78682
Bates, 2009, Clearance mechanisms of Alzheimer’s amyloid-β peptide: implications for therapeutic design and diagnostic tests., Mol. Psychiatry, 14, 469, 10.1038/mp.2008.96
Bernstein, 2008, Regional and cellular distribution patterns of insulin-degrading enzyme in the adult human brain and pituitary., J. Chem. Neuroanat., 35, 216, 10.1016/j.jchemneu.2007.12.001
Birch, 2014, Modulation of inflammation in transgenic models of Alzheimer’s disease., J. Neuroinflammation, 11, 10.1186/1742-2094-11-25
Blair, 2014, Accumulation of intraneuronal Amyloid-β is common in normal brain., Curr. Alzheimer Res., 11, 317, 10.2174/1567205011666140302200902
Brandenburg, 2008, Involvement of formyl-peptide-receptor-like-1 and phospholipase D in the internalization, and signal transduction of amyloid beta 1-42 in glial cells., Neuroscience, 156, 266, 10.1016/j.neuroscience.2008.07.042
Brandenburg, 2010, Functional and physical interactions between formyl-peptide-receptors and scavenger receptor MARCO and their involvement in amyloid beta 1–42-induced signal transduction in glial cells., J. Neurochem., 113, 749, 10.1111/j.1471-4159.2010.06637.x
Braun, 2011, The formyl peptide receptor like-1 and scavenger receptor MARCO are involved in glial cell activation in bacterial meningitis., J. Neuroinflammation, 8, 10.1186/1742-2094-8-11
Carare, 2008, Solutes, but not cells, drain from the brain parenchyma along basement membranes of capillaries and arteries: significance for cerebral amyloid angiopathy and neuroimmunology., Neuropathol. Appl. Neurobiol., 34, 131, 10.1111/j.1365-2990.2007.00926.x
Cascella, 2013, Extracellular chaperones prevent Aβ 42-induced toxicity in rat brains., Biochim. Biophys. Acta, 1832, 1217, 10.1016/j.bbadis.2013.04.012
Cho, 2014, Autophagy in microglia degrades extracellular β-amyloid fibrils and regulates the NLRP3 inflammasome., Autophagy, 10, 1761, 10.4161/auto.29647
Coraci, 2002, CD36, a class B scavenger receptor, is expressed on microglia in Alzheimer’s disease brains and can mediate production of reactive oxygen species in response to β-amyloid fibrils., Am. J. Pathol., 160, 101, 10.1016/S0002-9440(10)64354-4
Cramer, 2012, ApoE-directed therapeutics rapidly clear beta-amyloid and reverse deficits in AD mouse models., Science, 335, 1503, 10.1126/science.1217697
Cucullo, 2003, Blood-brain barrier damage induces release of alpha2-macroglobulin., Mol. Cell. Proteomics, 2, 234, 10.1074/mcp.M200077-MCP200
Deane, 2009, Clearance of amyloid-beta peptide across the blood-brain barrier: implication for therapies in Alzheimer’s disease., CNS Neurol. Disord. Drug Targets, 8, 16, 10.2174/187152709787601867
Doens, 2014, Microglia receptors and their implications in the response to amyloid beta for Alzheimer’s disease pathogenesis., J. Neuroinflammation, 11, 10.1186/1742-2094-11-48
Eckman, 2001, Degradation of the Alzheimer’s amyloid beta peptide by endothelin-converting enzyme., J. Biol. Chem., 276, 24540, 10.1074/jbc.M007579200
Eckman, 2003, Alzheimer’s disease beta-amyloid peptide is increased in mice deficient in endothelin-converting enzyme., J. Biol. Chem., 278, 2081, 10.1074/jbc.C200642200
El Khoury, 2003, CD36 mediates the innate host response to beta-amyloid., J. Exp. Med., 197, 1657, 10.1084/jem.20021546
Farfara, 2011, γ-Secretase component presenilin is important for microglia β-amyloid clearance., Ann. Neurol., 69, 170, 10.1002/ana.22191
Farris, 2003, Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo., Proc. Natl. Acad. Sci. U.S.A., 100, 4162, 10.1073/pnas.0230450100
Fisk, 2007, Effects of hypoxia and oxidative stress on expression of neprilysin in human neuroblastoma cells and rat cortical neurones and astrocytes., Neurochem. Res., 32, 1741, 10.1007/s11064-007-9349-2
Fu, 2012, Complement component C3 and complement receptor type 3 contribute to the phagocytosis and clearance of fibrillar Aβ by microglia., Glia, 60, 993, 10.1002/glia.22331
Fukami, 2002, Aβ-degrading endopeptidase, neprilysin, in mouse brain: synaptic and axonal localization inversely correlating with Aβ pathology., Neurosci. Res., 43, 39, 10.1016/S0168-0102(02)00015-9
Gopalan, 2006a, Astrocyte-specific expression of the alpha1-antichymotrypsin, and glial fibrillary acidic protein genes requires activator protein-1., J. Biol. Chem., 281, 1956, 10.1074/jbc.M510935200
Gopalan, 2006b, Nuclear factor-1-X regulates astrocyte-specific expression of the alpha1-antichymotrypsin, and glial fibrillary acidic protein genes., J. Biol. Chem., 281, 13126, 10.1074/jbc.M601194200
Gorina, 2009, Astrocytes are very sensitive to develop innate immune responses to lipid-carried short interfering RNA., Glia, 57, 93, 10.1002/glia.20738
Gouras, 2005, Intraneuronal Aβ accumulation, and origin of plaques in Alzheimer’s disease., Neurobiol. Aging, 26, 1235, 10.1016/j.neurobiolaging.2005.05.022
Halle, 2008, The NALP3 inflammasome is involved in the innate immune response to amyloid-β., Nat. Immunol., 9, 857, 10.1038/ni.1636
Harold, 2009, Genome-wide association study identifies variants at CLU, and PICALM associated with Alzheimer’s disease., Nat. Genet., 41, 1088, 10.1038/ng.440
Harris, 2004, Astroglial regulation of apolipoprotein E expression in neuronal cells. Implications for Alzheimer’s disease., J. Biol. Chem., 279, 3862, 10.1074/jbc.M309475200
Hickman, 2008, Microglial dysfunction, and defective beta-amyloid clearance pathways in aging Alzheimer’s disease mice., J. Neurosci., 28, 8354, 10.1523/JNEUROSCI.0616-08.2008
Holsinger, 2002, Increased expression of the amyloid precursor β-secretase in Alzheimer’s disease., Ann. Neurol., 51, 783, 10.1002/ana.10208
Hong, 2014, Relationship between amyloid-beta, and the ubiquitin–proteasome system in Alzheimer’s disease., Neurol. Res., 36, 276, 10.1179/1743132813Y.0000000288
Hu, 2001, Angiotensin-converting enzyme degrades Alzheimer amyloid β-peptide (Aβ); retards. (Aβ) aggregation, deposition, fibril formation; and inhibits cytotoxicity., J. Biol. Chem., 276, 47863, 10.1074/jbc.M104068200
Husemann, 2002, Scavenger receptors in neurobiology, and neuropathology: their role on microglia, and other cells of the nervous system., Glia, 40, 195, 10.1002/glia.10148
Igarashi, 2014, Water influx into cerebrospinal fluid is significantly reduced in senile plaque bearing transgenic mice, supporting beta-amyloid clearance hypothesis of Alzheimer’s disease., Neurol. Res., 36, 1094, 10.1179/1743132814Y.0000000434
Iribarren, 2005, CpG-containing oligodeoxynucleotide promotes microglial cell uptake of amyloid beta 1-42 peptide by up-regulating the expression of the G-protein- coupled receptor mFPR2., FASEB J., 19, 2032, 10.1096/fj.05-4578fje
Iwata, 2001, Subcellular compartment, and molecular subdomain of beta-amyloid precursor protein relevant to the Abeta 42-promoting effects of Alzheimer mutant presenilin 2., J. Biol. Chem., 276, 21678, 10.1074/jbc.M007989200
Jansen, 2014, The ubiquitin proteasome system in glia, and its role in neurodegenerative diseases., Front. Mol. Neurosci., 7, 10.3389/fnmol.2014.00073
Jones, 2013, Amyloid-β-induced astrocytic phagocytosis is mediated by CD36, CD47, and RAGE., J. Neuroimmune Pharmacol., 8, 301, 10.1007/s11481-012-9427-3
Kanekiyo, 2014, ApoE, and Aβ in Alzheimer’s disease: accidental encounters or partners?, Neuron, 81, 740, 10.1016/j.neuron.2014.01.045
Kimura, 2007, Aβ upregulates, and colocalizes with LGI3 in cultured rat astrocytes., Cell Mol. Neurobiol., 27, 335, 10.1007/s10571-006-9127-8
Kleinberger, 2014, TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis., Sci. Transl. Med., 6, 10.1126/scitranslmed.3009093
Klesney-Tait, 2006, The TREM receptor family, and signal integration., Nat. Immunol., 1266, 10.1038/ni1411
Koistinaho, 2004, Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-β peptides., Nat. Med., 10, 719, 10.1038/nm1058
Le, 2001, Amyloid ß42 activates a G-protein-coupled chemoattractant receptor, FPR-like-1., J. Neurosci., 21, 10.1523/JNEUROSCI.21-02-j0003.2001
Le, 2002, Formyl-peptide receptors revisited., Trends Immunol., 23, 541, 10.1016/S1471-4906(02)02316-5
Lee, 2010, The role of microglia in amyloid clearance from the AD brain., J. Neural. Transm., 117, 949, 10.1007/s00702-010-0433-4
Lee, 2015, Metallothionein-3 modulates the amyloid β endocytosis of astrocytes through its effects on actin polymerization., Mol. Brain., 8, 10.1186/s13041-015-0173-3
Leissring, 2003, Enhanced proteolysis of β-amyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature death., Neuron, 40, 1087, 10.1016/S0896-6273(03)00787-6
Li, 2013, P2Y4 receptor-mediated pinocytosis contributes to amyloid beta-induced self-uptake by microglia., Mol. Cell Biol., 33, 4282, 10.1128/MCB.00544-13
Lilienbaum, 2013, Relationship between the proteasomal system, and autophagy., Int. J. Biochem. Mol. Biol., 4, 1
Liu, 2005, LPS receptor (CD14): a receptor for phagocytosis of Alzheimer’s amyloid peptide., Brain, 128, 1778, 10.1093/brain/awh531
Love, 2004, Contribution of cerebral amyloid angiopathy to Alzheimer’s disease., J. Neurol. Neurosurg. Psychiatry, 75, 1
Lucin, 2013, Microglial beclin 1 regulates retromer trafficking and phagocytosis and is impaired in Alzheimer’s disease., Neuron, 79, 873, 10.1016/j.neuron.2013.06.046
Mandrekar, 2009, Microglia mediate the clearance of soluble Abeta through fluid phase macropinocytosis., J. Neurosci., 29, 4252, 10.1523/JNEUROSCI.5572-08.2009
Melchor, 2005, Tissue plasminogen activator in central nervous system physiology, and pathology., Thromb. Haemost., 93, 655, 10.1160/TH04-12-0838
Morris, 2014, The cerebrovascular basement membrane: role in the clearance of β-amyloid, and cerebral amyloid angiopathy., Front. Aging Neurosci., 6, 10.3389/fnagi.2014.00251
Mulder, 2014, Apolipoproteins E, and J interfere with amyloid-beta uptake by primary human astrocytes, and microglia in vitro., Glia, 62, 493, 10.1002/glia.22619
Nagele, 2003, Astrocytes accumulate Aβ42, and give rise to astrocytic amyloid plaques in Alzheimer disease brains., Brain Res., 971, 197, 10.1016/S0006-8993(03)02361-8
Naidoo, 2004, Cellular distribution of the endothelin system in the human brain., J. Chem. Neuroanat., 27, 87, 10.1016/j.jchemneu.2003.12.002
Nakagomi, 2000, Endothelin-converting enzymes, and endothelin receptor B messenger RNAs are expressed in different neural cell species, and these messenger RNAs are coordinately induced in neurons, and astrocytes respectively following nerve injury., Neuroscience, 101, 441, 10.1016/S0306-4522(00)00345-6
Nakanishi, 2003, Microglial functions, and proteases., Mol. Neurobiol., 27, 163, 10.1385/MN:27:2:163
Nalivaeva, 2012, Are amyloid-degrading enzymes viable therapeutic targets in Alzheimer’s disease?, J. Neurochem., 120, 167, 10.1111/j.1471-4159.2011.07510.x
Nixon, 2007, Autophagy, amyloidogenesis, and Alzheimer disease., J. Cell Sci., 120, 4081, 10.1242/jcs.019265
N’Songo, 2013, LRP1 plays a major role in the amyloid-β clearance in microglia., Mol. Neurodegener., 8, 10.1186/1750-1326-8-S1-P33
Okabayashi, 2008, Leucine-rich glioma inactivated 3 is involved in amyloid beta peptide uptake by astrocytes, and endocytosis itself., Neuroreport, 19, 1175, 10.1097/WNR.0b013e32830a4cc4
Okun, 2010, Involvement of Fc receptors in disorders of the central nervous system., Neuromolecular Med., 12, 164, 10.1007/s12017-009-8099-5
Pacheco-Quinto, 2013, Endothelin-converting enzymes degrade intracellular beta-amyloid produced within the endosomal/lysosomal pathway, and autophagosomes., J. Biol. Chem., 288, 5606, 10.1074/jbc.M112.422964
Pan, 2011, Microglial phagocytosis induced by fibrillar β-amyloid is attenuated by oligomeric β-amyloid: implications for Alzheimer’s disease., Mol. Neurodegener., 6, 1, 10.1186/1750-1326-6-45
Panaro, 2007, Formyl peptide receptors on immune, and nonimmune cells: analysis of sequence conservation in FPR genes., Immunopharmacol. Immunotoxicol., 29, 243, 10.1080/08923970701512544
Paresce, 1996, Microglial cells internalize aggregates of the Alzheimer’s disease amyloid β-protein via a scavenger receptor., Neuron, 17, 553, 10.1016/S0896-6273(00)80187-7
Peress, 1993, Identification of FcγRI, II, and III on normal human brain ramified microglia, and on microglia in senile plaques in Alzheimer’s disease., J. Neuroimmunol., 48, 71, 10.1016/0165-5728(93)90060-C
Pomilio, 2016, Glial alterations from early to late stages in a model of Alzheimer’s disease: evidence of autophagy involvement in Aβ internalization., Hippocampus, 26, 194, 10.1002/hipo.22503
Reed-Geaghan, 2009, CD14, and toll-like receptors 2 and 4 are required for fibrillar Aβ-stimulated microglial activation., J. Neurosci., 29, 11982, 10.1523/JNEUROSCI.3158-09.2009
Richard, 2008, Toll-like receptor 2 acts as a natural innate immune receptor to clear amyloid beta 1-42, and delay the cognitive decline in a mouse model of Alzheimer’s disease., J. Neurosci., 28, 5784, 10.1523/JNEUROSCI.1146-08.2008
Rock, 1994, Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules., Cell, 78, 761, 10.1016/S0092-8674(94)90462-6
Saido, 2012, Proteolytic degradation of amyloid beta-protein., Cold Spring Harb. Perspect. Med., 2, 10.1101/cshperspect.a006379
Sastre, 2015, Metal ions in Alzheimer’s disease brain., JSM Alzheimer’s Dis. Relat. Dement., 2
Saura, 2003, Microglial apolipoprotein E and astroglial apolipoprotein J expression in vitro: opposite effects of lipopolysaccharide., J. Neurochem., 85, 1455, 10.1046/j.1471-4159.2003.01788.x
Slowik, 2012, Involvement of formyl peptide receptors in receptor for advanced glycation end products(RAGE)-and amyloid beta 1-42-induced signal transduction in glial cells., Mol. Neurodegener., 7, 1, 10.1186/1750-1326-7-55
Solito, 2012, Microglia function in Alzheimer’s disease., Front. Pharmacol., 3, 10.3389/fphar.2012.00014
Steneberg, 2013, The type 2 diabetes-associated gene ide is required for insulin secretion and suppression of alpha-synuclein levels in beta-cells., Diabetes, 62, 2004, 10.2337/db12-1045
Stocker, 2004, Role of oxidative modifications in atherosclerosis., Physiol. Rev., 84, 1381, 10.1152/physrev.00047.2003
Tahara, 2006, Role of toll-like receptor signalling in Abeta uptake, and clearance., Brain, 129, 3006, 10.1093/brain/awl249
Tamboli, 2010, Statins promote the degradation of extracellular amyloid {beta}-peptide by microglia via stimulation of exosome-associated insulin-degrading enzyme (IDE) secretion., J. Biol. Chem., 285, 37405, 10.1074/jbc.M110.149468
Tang, 2016, Differential roles of M1, and M2 microglia in neurodegenerative diseases., Mol. Neurobiol., 53, 1181, 10.1007/s12035-014-9070-5
Tarasoff-Conway, 2015, Clearance systems in the brain - implications for Alzheimer disease., Nat. Rev. Neurol., 11, 457, 10.1038/nrneurol.2015.119
Trudler, 2010, Toll-like receptors expression, and signaling in glia cells in neuro-amyloidogenic diseases: towards future therapeutic application., Mediators Inflamm., 2010, 10.1155/2010/497987
Utter, 2008, Cerebral small vessel disease-induced apolipoprotein E leakage is associated with Alzheimer disease and the accumulation of amyloid beta-protein in perivascular astrocytes., J. Neuropathol. Exp. Neurol., 67, 842, 10.1097/NEN.0b013e3181836a71
van Noort, 2009, Toll-like receptors in the CNS: implications for neurodegeneration, and repair., Prog. Brain Res., 175, 139, 10.1016/S0079-6123(09)17509-X
Verghese, 2013, ApoE influences amyloid-beta (Abeta) clearance despite minimal apoE/Abeta association in physiological conditions., Proc. Natl. Acad. Sci. U.S.A., 110, E1807, 10.1073/pnas.1220484110
Wang, 2010, Expression and functional profiling of neprilysin, insulin-degrading enzyme, and endothelin-converting enzyme in prospectively studied elderly and Alzheimer’s brain., J. Neurochem., 115, 47, 10.1111/j.1471-4159.2010.06899.x
Wang, 2015, TREM2 lipid sensing sustains the microglial response in an Alzheimer’s disease model., Cell, 160, 1061, 10.1016/j.cell.2015.01.049
Wang, 2016, TREM2-mediated early microglial response limits diffusion and toxicity of amyloid plaques., J. Exp. Med., 213, 667, 10.1084/jem.20151948
Wilcock, 2003, Intracranially administered anti-Abeta antibodies reduce beta-amyloid deposition by mechanisms both independent of and associated with microglial activation., J. Neurosci., 23, 3745, 10.1523/JNEUROSCI.23-09-03745.2003
Wildsmith, 2013, Evidence for impaired amyloid beta clearance in Alzheimer’s disease., Alzheimers Res. Ther., 5, 10.1186/alzrt187
Yamamoto, 2014, Leptin inhibits amyloid β-protein degradation through decrease of neprilysin expression in primary cultured astrocytes., Biochem. Biophys. Res. Commun., 445, 214, 10.1016/j.bbrc.2014.01.168
Yamauchi, 2013, Low-density lipoprotein receptor related protein-1 (LRP1)-dependent cell signaling promotes neurotrophic activity in embryonic sensory neurons., PLoS ONE, 8, 10.1371/journal.pone.0075497
Yan, 2006, Matrix metalloproteinase-9 degrades amyloid-beta fibrils in vitro and compact plaques in situ., J. Biol. Chem., 281, 24566, 10.1074/jbc.M602440200
Yang, 2011, Mechanism mediating oligomeric Aβ clearance by naïve primary microglia., Neurobiol. Dis., 42, 221, 10.1016/j.nbd.2011.01.005
Yang, 2003, Elevated β-secretase expression, and enzymatic activity detected in sporadic Alzheimer disease., Nat. Med., 9, 3, 10.1038/nm0103-3
Yin, 2006, Matrix metalloproteinases expressed by astrocytes mediate extracellular amyloid-beta peptide catabolism., J. Neurosci., 26, 10939, 10.1523/JNEUROSCI.2085-06.2006
Yoon, 2012, Mechanisms of amyloid-β peptide clearance: potential therapeutic targets for Alzheimer’s disease., Biomol. Ther., 20, 245, 10.4062/biomolther.2012.20.3.245
Zhao, 2010, Amyloid-β peptide is a substrate of the human 20S proteasome., ACS Chem. Neurosci., 1, 655, 10.1021/cn100067e
Zhao, 2007, M. Insulin degrading enzyme activity selectively decreases in the hippocampal formation of cases at high risk to develop Alzheimer’s disease., Neurobiol. Aging, 28, 824, 10.1016/j.neurobiolaging.2006.05.001